Sclerosis D012598

Description

A pathological process consisting of hardening or fibrosis of an anatomical structure, often a vessel or a nerve.   MeSH

Hierarchy View


Phase 1 Indicated Drugs (2)


Organization Involved with Phase 4 Indications (110)

Organization Involved with Phase 3 Indications (264)

Government of Canada

Government of France

Griffith University

GW Research

Hampton Roads Neurology

Haugesund Hospital

Helse Forde

Hoosier Cancer Research Network

Hopital Maison Blanche

Hospital of Central Denmark Region, Viborg, Denmark

Hospital of South West Jutland

Humanitas Mirasole SpA

Humboldt University

Icahn School of Medicine at Mount Sinai

ICM - Brain & Spine Institute

Impax Laboratories

Indiana University

Indivior Inc.

Institut fur Klinische Forschung, Germany

Iowa Health Des Moines

Ipsen

Island Neurological Associates, PC

Istituto Don Carlo Gnocchi Divisione Neurologica Riabilitativa. Via Capecelatro 66 20148 Milano

Istituto Superiore di Sanità

Italian Multiple Sclerosis Foundation

Japan Agency for Medical Research and Development

Jiao Tong University

Josephson Wallack Munshower Neurology, PC

Karolinska Institute

KhonKaen University

Klinikum Luedenscheid

Knopp Biosciences

Kocaeli University

Kyowa Hakko Kirin

Lillehammer Hospital

Loma Linda University

Lundbeck

Macquarie University

Mapi Pharma Ltd.

Mayo Clinic

Mazandaran University of Medical Sciences

MedDay Pharmaceuticals

Medical University of South Carolina

MediciNova

Melbourne Health

Mercy Multiple Sclerosis Center of Oklahoma Mercy Neuroscience Institute

Metrolina Medical Research

Mitsubishi Tanabe

Molde University College

MonitorCRO

Multiple Sclerosis Society of Canada

National Cancer Institute (NCI)

National Center for Research Resources (NCRR)

National Institute of Allergy and Infectious Diseases (NIAID)

National Institute of Neurological Disorders and Stroke (NINDS)

National Taiwan University

Negroski, Stein, Sutherland and Hanes Neurology

Neurologique Foundation, Inc.

Neurology Center of New England P.C.

Neurology Specialists, Inc.

Nobel Pharmaceuticals

Nordland Hospital

North Central Neurology Associates, PC

Northwestern University

Norwegian University of Science and Technology

Nuron Biotech

Ohio State University

Okayama University

Oregon Health and Science University

Orphazyme

Osaka University

Oslo Metropolitan University

Osmotica Pharmaceutical

Ospedale Civile di Chivasso

Ospedale Generale di Bolzano

Ospedale Generale di Macerata

Ospedale Maggiore San Giovanni Bosco

Ospedale SAntonio Abate Servizio recupero Neurologico

Ospedale S. Croce

Pennsylvania State University

Phoenix Neurological Associates, LTD

Pierre Fabre

Policlinico Universitario Centro Sclerosi Multipla

Polpharma

Presbyterian/St. Luke's Medical Center, Denver

Princess Beatrix Muscle Foundation

Pronova BioPharma

Providence Health & Services

Raleigh Neurology Associates

Region Syddanmark

Rhode Island Hospital

Rivermead Rehabilitation Centre

Royal Berkshire and Battle Hospitals NHS Trust

Ruan Neurology Clinical Research Center

Russian State Medical University

Serono

Shanghai Genomics, Inc.

Sheffield Hallam University

Shepherd Center, Inc.

Sibyl E. Wray, MD, Neurology, PC

Sorlandet Hospital HF

South Shore Neurologic Associates

Southwest Oncology Group

Springfield Neurology Associates, LLC

Stanford University

State University of New York, Syracuse

Suncoast Neuroscience Associates, Inc.

Sykehuset Innlandet HF

Sykehuset i Vestfold HF

Sykehuset Ostfold

Taiyo

Telemark Hospital Trust

Temple University

Texas Neurology

Texas Tech University

TG Therapeutics, Inc.

The Avicena Group

The Immune Response Corporation

The Multiple Sclerosis Center of Vero Beach

The Multiple Sclerosis National Competence Centre

The Neurological Institute, PA

The Norwegian Multiple sclerosis Society

Tokyo University

Trinity College Dublin

Trophos

Tufts University

Unifour Medical Research, LLC

Universidad Autonoma de Madrid

Universidad Autonoma de Nuevo Leon

University Hospital, Tours

University of Adelaide

University of Bergen

University of Bordeaux

University of Brescia

University of British Columbia

University of Caen-Normandie

University of Calgary

University of California, San Diego

University of Colorado, Denver

University of Connecticut

University of Copenhagen

University of East Anglia

University of Edinburgh

University of Ferrara

University of Heidelberg

University of Kansas

University of Kentucky

University of Leeds

University of Lille

University of Lisbon

University of Liverpool

University of London

University of Lyon

University of Maryland

University of Massachusetts

University of Miami

University of Milan

University of Missouri, Kansas City

University of Modena and Reggio Emilia

University of Nantes

University of Nice Sophia Antipolis

University of Oslo

University of Padova

University of Paris

University of Pavia

University of Pennsylvania

University of Perugia

University of Pittsburgh

University of Plymouth

University of Rennes

University of Roma La Sapienza

University of Sao Paulo

University of South Carolina

University of Southern California

University of Stavanger

University of Tehran

University of Texas, San Antonio

University of Tokushima

University of Toronto

University of Tromso

University of Turin

University of Ulm

University of Vermont

University of Verona

University of Virginia

University of Western Ontario

University of Wisconsin

Uppsala University

Upstate Clinical Research

Utrecht University

Vestre Viken Ringerike Sykehus

Vita-Salute University of Milano. Italy

Wayne State University

Weleda AG

West Virginia University

Wyeth

Yale University

Zenyaku Kogyo Co., Ltd.

Organization Involved with Phase 2 Indications (289)

Academic MS Center Limburg

Active Biotech AB

Advancell - Advanced In Vitro Cell Technologies, S.A.

Agenzia Italiana del Farmaco

Albany Medical College

Alberta Innovates Health Solutions

ALS Canada

ALS Finding a Cure Foundation

ALS Therapy Alliance

ALS Therapy Development Institute

Alzahra University

American University of Beirut

Andalusian Initiative for Advanced Therapies

Andalusian Initiative in Advanced Therapies

Annexon

Apellis Pharmaceuticals, Inc.

ApoPharma

Apricus Biosciences

Aquestive Therapeutics

Aspreva Pharmaceuticals

Aucta Pharms

Autism Speaks

Avigen

AZTherapies, Inc.

Banc de Sang i Teixits

Bar Ilan University

Barnet and Chase Farm Hospitals NHS Trust

Barrow Neurological Institute

Basildon and Thurrock University Hospitals NHS Foundation Trust

Bayhill Therapeutics

Beike Biotech

Bennett, James P., Jr., M.D., Ph.D.

Bioelectron

Bioinova, s.r.o.

Brain Canada

Brain Chemistry Labs, Institute for EthnoMedicine

Brainstorm Cell Therapeutics

Bristol-Myers Squibb

BTG

Buffalo Neuroimaging Analysis Center

Calvary Health Care Bethlehem

Cambridge Antibody Technology

Canbex Therapeutics Ltd

Cardiff University

Catholic University of Sacred Heart, Rome

Center for Neurologic Study, La Jolla, California,

Centocor

Centre Hospitalier de PAU

Chaitanya Hospital

Chang Gung University

Chiba University

Chinese Academy of Medical Sciences

CH Pau

City of Hope National Medical Center

Clinica Universidad de Navarra

Clinique de sclérose en plaques et neuromusculaire de l'Outaouais

Cognition Therapeutics

Coherus BioSciences

Consortium of Multiple Sclerosis Centers

Corestem, Inc.

Covance

CSL Behring

Cumberland Pharmaceuticals

CytRx

Danish Research Centre for Magnetic Resonance

Dartmouth University

Daval International Limited

Delta Crystallon BV

Digna Biotech S.L.

El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez

Emerald Health Pharmaceuticals

Emory University

Fédération Hospitalo-Universitaire NEUROGENYCS

Flex Pharma, Inc.

Fondation ARSEP/AFM

Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico, Milano

Forbes Norris MDA/ALS Research Center

Fraunhofer

Fundación Pública Andaluza

Fundación Universidad Católica de Valencia San Vicente Mártir

Galapagos NV

Genesis Institute of Cellular Medicine

Genesis Limited

GeNeuro

Genuv Inc.

German Federal Ministry of Education and Research

German Research Foundation

Ghent University

GlaxoSmithKline

Government of Poland

Government of Spain

Grifols

Gunma University

Hadassah Medical Organization

Hanyang University

Health Sciences Centre Foundation, Manitoba

Hebrew University

Helixmith Co., Ltd.

Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

Human Genome Sciences

ICON

ImCyse

Immune Tolerance Network

Immunic AG

Immunity Pharma Ltd.

Implicit Bioscience

INC Research

Innate Immunotherapeutics

Innobioscience SpA

Institut d'Investigacions Biomèdiques August Pi i Sunyer

InteKrin Therapeutics, Inc.

inVentiv

Inventiva Pharma

IQVIA

IRCCS National Neurological Institute C. Mondino Foundation

ISDIN

Isfahan neurosciences research center

Istituto Auxologico Italiano

Istituto Biostrutture e Immagini, CNR Naples

Jacobs Neurological Institute

Jordan University

J. W. Goethe University

Kadimastem

Kadmon

Kangbuk Samsung Hospital

Keele University

Kessler Foundation

King Saud University

Knopp Neurosciences Inc.

Leandro P. Rizzuto Foundation

Lund University

Maastricht University

Manitoba Medical Service Foundation

Marinus Pharmaceuticals

Mario Negri Institute

Maryland Center for MS

Max Planck Institute

McGill University

Medical Research Council

Medtronic

Methodist Cancer Center, Houston, Texas

Michigan Medical P.C. Neurology

Michigan State University

Millennium Pharmaceuticals

MitoQ Ltd

MorphoSys

MS Hub Medical Group

MS Society

Multiple Sclerosis Institute

Multiple Sclerosis Society of Great Britain and Northern Ireland

Muscular Dystrophy Association

Nanjing Medical University

Nanjing University

National Center for Complementary and Integrative Health (NCCIH)

National Center of Neurology and Psychiatry, Japan

National Institute for Health Research, United Kingdom

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Neuraltus Pharmaceuticals, Inc.

Neuregenix

Neurocrine Biosciences

NeuroCure Clinical Research Center

Neurogen Brain and Spine Institute

Neuroscience Trials Australia

Neurotec Pharma

Newron Pharmacueticals

Northeast ALS Consortium

Novo Cellular Medicine Institute LLP

Office of Dietary Supplements (ODS)

OMNI Medical Services, LLC

Ono Pharmaceuticals

Ontario Institute for Regenerative Medicine (OIRM)

Opexa Therapeutics

Orion Corporation

OvaMed GmbH

PDL BioPharma

Peking University

PharmaPart

PhytoTech Therapeutics, Ltd.

Polski Bank Komorek Macierzystych JSC (PBKM)

Pontificia Universidad Catolica de Chile

Primorus Clinical Trials

Prism Research

PSI CRO

Q Therapeutics, Inc.

Queen's University, Belfast

RedHill Biopharma

Regeneron

RemeGen

Revalesio Corporation

Rockefeller University

Rockwood Clinic, PS

Rocky Mountain MS Research Group

Royal Brisbane & Women's Hospital

Royan Institute

Rudolph Rupert Scleroderma Program

Ruhr University Bochum

Salford Royal Foundation NHS Trust

Samus Therapeutics

Sangamo BioSciences

Sanofi-Aventis

Schering-Plough

Scleroderma Research Consultants LLC

Seattle Genetics

Seizure Tracker LLC

Servier

SGS Life Sciences

Signifikans ApS

Singapore General Hospital

SocraMetrics GmbH

South-Eastern Norway Regional Health Authority

Southend University Hospital Foundation NHS Trust

Statens Serum Institut

State of Minnesota

Stem Cell Medicine Ltd.

Stem Cells Arabia

St. Louis University

Stony Brook University

Sutter East Bay Medical Foundation

Tabriz Medical University

Taipei Medical University

Texas Oncology Cancer Center

The Albion Centre

The Danish Multiple Sclerosis Society

The LAM Foundation

The Multiple Sclerosis Center of Atlanta

The Salah Foundation

The Swedish Research Council

The Tuberous Sclerosis Association

Thomas Jefferson University

TikoMed AB

Translational Biosciences

Tuberous Sclerosis Alliance

Umea University

Universidad Austral de Chile

Universidad Autonoma de Barcelona

Universidad Carlos III Madrid

University Hospital Motol, Prague, Czech Republilc

University of Alabama, Birmingham

University of Alberta

University of Arizona

University of Barcelona

University of Bari

University of Basel

University of Bern

University of Birmingham

University of Cambridge

University of Campania Luigi Vanvitelli

University of Chile

University of Cincinnati

University of Eastern Piedmont

University of Florida

University of Genova

University of Hamburg

University of Hull

University of Jordan

University of Louisville

University of Malaya

University of Manchester

University of Minnesota

University of Montpellier

University of Montreal

University of Naples Frederico II

University of Otago

University of Ottawa

University of Oxford

University of Palermo

University of Seville

University of Strasbourg

University of Sussex

University of Sydney

University of Tennessee

University of Utah

University of Vienna

University of Warwick

University of Zurich

Vanderbilt University

Versus Arthritis

Vicore Pharma AB

Viollier AG

ViroMed

Wenatchee Valley Medical Center

Western ALS Study Group

Western Institute for Biomedical Research, Salt Lake City, UT

Winthrop University

Worldwide Clinical Trials

Xuzhou Medical University

Yiling Pharmaceutical Inc.

Yoshino Neurology Clinic

ZonMw: The Netherlands Organisation for Health Research and Development

Organization Involved with Phase 1 Indications (67)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.